DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Zinman B, Wanner C, Lachin JM et al.
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
N Engl J Med 2015;
373: 2117-2128
We do not assume any responsibility for the contents of the web pages of other providers.